# Nabilone for Non-motor Symptoms in Parkinson's Disease

> **NCT03773796** · PHASE3 · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 22 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Nabilone 0.25 mg

## Key facts

- **NCT ID:** NCT03773796
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-06
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773796, "Nabilone for Non-motor Symptoms in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03773796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*